- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Epigral Limited — Updates, 10-11-2025: Press Release
10-11-2025 | 01:28 pm
10-11-2025 | 01:28 pm
Epigral's Q2FY26 revenue dropped to ₹589 Cr (vs ₹632 Cr YoY) with PAT at ₹51 Cr (vs ₹81 Cr YoY) due to lower volume/realization. H2FY26 outlook is positive post monsoon/maintenance. Capacity expansions for CPVC, Epichlorohydrin, and power are on schedule for FY2027 growth.
No comments yet. Be the first to comment!